Announcement

Collapse
No announcement yet.

Clin Rheumatol . Kawasaki disease and influenza-new lessons from old associations

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Clin Rheumatol . Kawasaki disease and influenza-new lessons from old associations


    Clin Rheumatol


    . 2021 Jan 2.
    doi: 10.1007/s10067-020-05534-1. Online ahead of print.
    Kawasaki disease and influenza-new lessons from old associations


    Aaqib Zaffar Banday 1 , Ashwini Arul 1 , Pandiarajan Vignesh 2 , Mini P Singh 3 , Kapil Goyal 3 , Surjit Singh 1



    AffiliationsFree PMC article

    Abstract

    Kawasaki disease (KD), an enigmatic medium vessel vasculitis, presents as an acute febrile illness predominantly affecting young children. KD appears to be a hyper-inflammatory response elicited by environmental or infectious agents (including respiratory viruses) in genetically predisposed individuals. Numerous reports from the current era of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic have described the occurrence of KD/KD-like illness in close temporal proximity to SARS-CoV-2 infection or exposure. Notably, KD has been reported in association with H1N1-pdm09 virus that caused the previous pandemic a decade ago. Non-H1N1 influenza infections as well as influenza vaccination have also been reported to trigger KD. Herein, we report a case of H1N1-pdm09 influenza who developed KD. We review the published literature on influenza infection or vaccination triggering KD. This may help in a better understanding of the KD/KD-like illness associated with SARS-CoV-2. Besides, we also evaluate the safety of aspirin in influenza-triggered KD as aspirin administration in children with influenza is associated with the risk of development of Reye syndrome.

    Keywords: Aspirin; COVID-19; Coronavirus; Influenza; Kawasaki disease; SARS-CoV-2; Vaccine.

Working...
X